Editas Medicine Stock Shows Improved Relative Strength Rating

In a welcome move, Editas Medicine (EDIT) saw its Relative Strength Rating improve from 66 to 71 on Thursday.


When looking for the best stocks to buy and watch, be sure to pay attention to relative price strength.

This proprietary rating measures technical performance by showing how a stock’s price movement over the last 52 weeks measures up against that of the other stocks in our database.

Over 100 years of market history shows that the market’s biggest winners typically have an RS Rating of over 80 as they begin their biggest price moves. See if Editas Medicine can continue to show renewed price strength and clear that threshold.

See How IBD Helps You Make More Money In Stocks

Since hitting a 52-week high of 99.95 on Jan. 8, Editas Medicine stock has pulled back in a long cup-shaped consolidation. It’s now out of a proper buy zone but this biotech stock is worth putting on your watch list. Look for the stock to create a new chance to pick up shares like a three-weeks tight or pullback to the 50-day or 10-week line. Read “Looking For The Next Big Stock Market Winners? Start With These 3 Steps” for more tips. Also, check out “Stocks To Buy And Watch: Top IPOs, Big And Small Caps, Growth Stocks.”


While earnings-per-share growth declined last quarter from 0% to -24%, revenue grew 14%, up from -7% in the previous report. The next quarterly results are expected on or around Aug. 6.

Editas Medicine stock holds the No. 158 rank among its peers in the Medical-Biomed/Biotech industry group. Maravai Lifesciences (MRVI) and Avid Bioservices (CDMO) are also among the group’s highest-rated stocks. For more industry news, check out “Biotech And Pharmaceutical Industry And Stock News.”


MarketSmith’s Tools Can Help The Individual Investor

IBD Live: A New Tool For Daily Stock Market Analysis

Profit From Short-Term Trends With SwingTrader

How To Research Growth Stocks: Why This IBD Tool Simplifies The Search For Top Stocks

Most Related Links :
todayprimenews Governmental News Finance News

Source link

Back to top button